DalCor Pharmaceuticals Closes USD80M Series D Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Dalcor Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dalcor Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dalcor Pharmaceuticals Today - Breaking & Trending Today
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
This 32-country randomized clinical trial assesses the effects of bempedoic acid on cardiovascular outcomes in statin-intolerant patients receiving bempedoic ac
Source: jamanetwork.com
Global Cardiovascular Partnering 2023: Trends, Players and Financials for Every Deal Since 2016
/PRNewswire/ -- The "Global Cardiovascular Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's...
Source: prnewswire.com
dal-GenE Phase 3 Cardiovascular Precision Medicine Outcomes Trial Results Published in European Heart Journal
Trial was negatively impacted by the COVID-19 pandemic and did not meet the primary endpoint. However, the results validate the interaction between dalcetrapib treatment and AA genotype at variant rs1967309 in the ADCY9 gene.
Source: dicardiology.com
New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes | Acute Coronary Syndromes | JAMA
This Viewpoint summarizes the pathophysiology and clinical features of atherosclerotic plaque erosion as an underlying mechanism of acute coronary syndromes (AC
Source: jamanetwork.com